https://orcid.org/0000-0001-6296-9907
References
- Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS statistical report: primary brain and other Central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol. 2019;21(Suppl 5):v1–v100.
- Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820.
- Villa S, Balana C, Comas S. Radiation and concomitant chemotherapy for patients with glioblastoma multiforme. Chin J Cancer. 2014;33(1):25–31.
- Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756–760.
- Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–466.
- Kim VN, Nam JW. Genomics of microRNA. Trends Genet. 2006;22(3):165–173.
- Li Z, Rana TM. Molecular mechanisms of RNA-triggered gene silencing machineries. Acc Chem Res. 2012;45(7):1122–1131.
- Caponnetto F, Dalla E, Mangoni D, et al. The miRNA content of exosomes released from the glioma microenvironment can affect malignant progression. Biomedicines. 2020;8(12):564.
- Moller HG, Rasmussen AP, Andersen HH, et al. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol. 2013;47(1):131–144.
- Chenarani N, Emamjomeh A, Allahverdi A, et al. Bioinformatic tools for DNA methylation and histone modification: a survey. Genomics. 2021;113(3):1098–1113.
- Nazarov PV, Kreis S. Integrative approaches for analysis of mRNA and microRNA high-throughput data. Comput Struct Biotechnol J. 2021;19:1154–1162.
- Chepied A, Daoud-Omar Z, Meunier-Balandre AC, et al. Involvement of the gap junction protein, Connexin43, in the formation and function of invadopodia in the human U251 glioblastoma cell line. Cells. 2020;9(1):117.
- Delic S, Lottmann N, Stelzl A, et al. MiR-328 promotes glioma cell invasion via SFRP1-dependent wnt-signaling activation. Neuro Oncol. 2014;16(2):179–190.
- Luan W, Ding Y, Xi H, et al. Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4. J Exp Clin Cancer Res. 2021;40(1):107.
- Zhang Z, Tang H, Wang Z, et al. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer. 2011;10:124.
- Qian Z, Li Y, Fan X, et al. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. J Neurooncol. 2018;137(1):127–137.
- Yuan GQ, Wei NL, Mu LY, et al. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. CBM. 2017;20(4):443–452.
- Bookman MA. Can we predict who lives long with ovarian cancer? Cancer. 2019;125(Suppl 24):4578–4581.
- Wu D, Wang C. miR-155 regulates the proliferation of glioma cells through PI3K/AKT signaling. Front Neurol. 2020;11:297.
- Chen G, Chen Z, Zhao H. MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1. J Cell Mol Med. 2020;24(9):5363–5374.
- Li Y, Xu J, Zhang J, et al. MicroRNA-346 inhibits the growth of glioma by directly targeting NFIB. Cancer Cell Int. 2019;19:294.
- Ma R, Yan W, Zhang G, et al. Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype. PLoS One. 2012;7(6):e38096.
- Huang X, Xiao S, Zhu X, et al. miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling. Cell Death Dis. 2020;11(9):785.
- Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, et al. miR-196b-5p regulates colorectal cancer cell migration and metastases through interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017;23(17):5255–5266.
- Korshunov A, Okonechnikov K, Sahm F, et al. Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker. Acta Neuropathol. 2020;139(3):583–596.